🎧 Listen to the Discussion(two hosts talk through their thoughts on this article)

Audio only — for listening on a walk or while doing chores

This is an AI-generated audio overview of this article, created with Google NotebookLM. Two hosts discuss the article together, sharing their own thoughts and commentary — it is not a reading of the article text.

This article is a record based on published results and my own thoughts. It is not a recommendation to buy or sell any particular share.

I explained why I chose these ten companies in the article "Ten Japanese and American Companies Chosen with a Gardener's Eye: Investing in Shares Like Making a Garden at 66".

An older woman's hand gently touching a baby's small hand

A hand that has lived many years, and a hand that has only just begun. Unicharm makes nappies that support daily life at both ends.
Photo by Rod Long on Unsplash

On Friday 6 November, at 4 p.m. after the Tokyo market closed (7 a.m. in Britain), Unicharm announced its results for the third quarter of the year to December 2026 – that is, for the nine months from January to September. In the "Garden of Ten" results notes, this is the third check on the roses layer, following Microsoft and Daikin Industries.

Three Numbers – Did They Beat Expectations?

There is something I must say honestly at the start. This time, I could not confirm the market forecasts for sales and earnings per share (EPS) from the compilers this series uses. I tried the pages of Reuters (LSEG), the Nikkei, Kabutan and IFIS, but nowhere could I find actual forecast figures for July–September sales or EPS.

Item Market forecast Actual (January–September) Difference Verdict
Sales Could not be confirmed 729.3 billion yen (+5.1% year on year). July–September 242.2 billion yen (+5.3%) – Not judged
EPS Could not be confirmed 32.88 yen (−5.2%). July–September 9.1 yen (−15.7%) – Not judged
Company's full-year forecast IFIS compilation about 4% above the company's pre-tax profit forecast (amount not stated) Kept: sales 1.015 trillion yen, core operating profit 113 billion yen, net profit 70 billion yen – IN LINE
Unicharm (8113)Close ¥1,034.5 on 26 Oct
¥1,050.5¥885.3MayJunJulAugSepOct

Data: Yahoo Finance. The line shows daily closing prices. This is my own record, not investment advice. View on TradingView

I marked sales and EPS "not judged" because of this series' rules. There was one figure worth noting for reference. An Investing.com article says that Profit from the core business: sales minus the cost of sales and selling and administrative expenses. Unicharm reports it under International Financial Reporting Standards (IFRS), excluding one-off gains and losses, and it is close to "operating profit" under Japanese accounting rules. for July–September was 24.4 billion yen, below a forecast of 28.2 billion yen. But it does not say which compiler that forecast came from. I felt that writing "missed expectations" on the basis of a forecast of unknown origin would lower the value of this record, so I did not use it for the verdict.

Instead, I took out the three months from July to September myself. Sales were 242.2 billion yen, about 5% higher than in the same three months a year earlier. Core operating profit, however, was 24.4 billion yen, down 17.5% from 29.6 billion yen, and net profit was 15.7 billion yen, down 16.9% (the same as in Kabutan's table).

There is a reason why pre-tax profit for the nine months fell by 0.7%. According to a note in the results brief, last year's "other income" included 5.3 billion yen of insurance money for a fire in 2020 at the Ahmedabad factory in India. There was no such income this year, so the fall is partly only on paper. Measured by core operating profit, the profit from the core business, the nine months show an increase of 3.3%. Over the nine months, sales and profit both look higher; but in the latest three months, sales grew while profit thinned.

For the full-year outlook, the company kept unchanged the forecast it revised at its half-year results in August (sales of 1.015 trillion yen, core operating profit of 113 billion yen, and profit attributable to owners of the parent of 70 billion yen). The results brief says it is "unchanged from the announcement of 5 August 2026". As the yardstick says, I marked it IN LINE because the forecast was kept. However, IFIS Kabuyoho writes that the company's pre-tax profit forecast is 4% below the IFIS consensus. In other words, analysts are more optimistic than the company; if October–December ends up as the company expects, it may be the analysts' figures that come down. Progress towards the net profit forecast after nine months is 81.0%, almost the same as the five-year average of 79.9% (Kabutan).

As for the share price, the announcement came after Friday's trading, so the first day of trading in Tokyo is Monday 9 November. The American depositary receipts traded over the counter in the US (UNICY) fell 0.29 dollars (8.2%) to 3.23 dollars in trading on the 6th (The Stock Observer). I do not know what the share price will do from here, and I make no prediction about it in this article.

Horizontal bars showing growth in core operating profit by region for January–September. Japan +5.1%, Other (North America, Brazil and elsewhere) +11.5%, Asia −18.3%

Growth in profit from the core business by region (January–September, year on year). Japan and Other grew; only Asia fell sharply.

What Went Well, and What Still Worries Me

In the original article, I put this company in the roses layer: a flower that blooms well, but easily falls ill if you neglect its care. These results showed that even on a single rose bush, some branches catch the sun and others catch a cold wind.

The branch in the sun is Japan. Sales in Japan for January–September were 251.5 billion yen, up 2.6%, and core operating profit was 50.8 billion yen, up 5.1%. Profit as a share of sales was 20.2%, 0.5 points higher than a year earlier. The company's presentation says that even as raw material prices rose sharply, it kept sales and profit growing by "passing on value" – raising prices in line with the worth of its products – while holding on to its share of the shelf.

Another branch grew well too: pet care. Sales were 127.8 billion yen, up 13.0%, and profit was 21.7 billion yen, up 12.4%. The newly added pet-food company in Brazil also helped. The "Other" region, which includes North America and Brazil, saw sales rise 15.1% and profit 11.5%.

The branch in the cold wind is Asia. Sales were 296.6 billion yen, up 1.7%, but down 3.7% in real terms once exchange rates are set aside, and core operating profit was 12.3 billion yen, down 18.3%. In real terms, profit fell 26.3%. Looking at real sales by country, China fell 17% and Thailand 7%, while India rose 2%, Indonesia 3% and Vietnam 8%. In China, the company writes, damage from harmful rumours hit sanitary products for a time, and the recovery is slow.

The Indian tax that I named as a concern in the original article shows up in the figures again. A write-down related to India's Goods and Services Tax, India's equivalent of VAT. Unicharm has recorded a write-down of assets related to GST in India. came to 2.7 billion yen over the nine months, and 6.9 billion yen is expected for the full year. The company explains that profit in Asia is "effectively level with last year, excluding the Indian GST write-down". Put another way, even without the tax burden, it has not yet recovered to above last year's level. In Asia, up-front investment to spread nappies and adult products is also weighing on profit.

Overall, while costs rose sharply, gross profit as a share of sales improved by 1.0 point. But selling and administrative expenses as a share of sales worsened by 1.2 points. Price rises won back the higher costs, but the company is putting that money into advertising, shop displays and staff. The weak yen lifted sales by about 29.8 billion yen and core operating profit by about 3.0 billion yen.

Are My Reasons for Planting It Still Sound?

In the original article, my reason for putting Unicharm in my garden was that, as Asia ages, adult nappies will become a necessity of daily life.

On this reason, the results brief says that in Thailand, Indonesia and Vietnam, "latent demand for adult incontinence products is growing". The company is building product ranges matched to the level of care needed (ADL, activities of daily living), and in Thailand it has begun selling lower-priced pants in convenience stores and elsewhere. In China, it says, ageing is advancing rapidly, yet dedicated products are still little known, and many people make do with sanitary pads or bed sheets; so it is adding products for light bladder leakage. In Japan it keeps the top market share, and the number of people using its advice service on adult nappies reached about 182,000 at the end of June (presentation). Yet the sales and profit figures for adult incontinence care itself appear neither in the results brief nor in the text of the presentation. The company gives figures only for "personal care", which combines adult, feminine and baby products; its sales rose 3.4% and its profit was the same as a year earlier. The reason itself still holds, but the support in numbers remains thin this time.

What about the worrying side? The Indian tax write-down continues, with 6.9 billion yen expected for the full year. On top of that, a concern I did not stress in the original article has come clearly into view: a 17% fall in real sales in China. The 18% fall in Asian profit cannot be explained by India alone. My reading is that the "recovery from the fall in profit" has not yet begun in Asia, even after nine months.

Let me apply the five questions. (1) Does it keep creating new things? Adult products matched to people's physical condition, and a new branch in Brazilian pet food, are the answers for these nine months. (2) Does the base of its profit hold firm even in a year of headwinds? Japan kept a 20% margin, and overall core operating profit rose 3.3%. But the latest three months showed a fall of about 18%, so the answer to this question has wavered a little since the original article. (3) Does it have plenty of cash, so it can act on its own judgement when a chance comes? Cash at the end of September was 232.5 billion yen, and borrowings totalled less than 15 billion yen. The equity attributable to owners of the parent was 65.7% of total assets, up from 65.0% at the start of the year. On that footing, it completed a share buyback of about 19 billion yen and bought the Brazilian pet-food company for about 22 billion yen. (4) Does it keep spending on research and equipment even at the bottom of the cycle? Research and development spending was 10.3 billion yen over the nine months, up from 7.8 billion yen a year earlier (though about 2.0 billion yen of this reflects a change in what is counted). Advertising also rose, to 27.2 billion yen, and in Asia it keeps investing ahead even at the cost of profit. On the other hand, spending on equipment fell to 15.4 billion yen from 22.4 billion yen. (5) Can it talk with long-term shareholders about years rather than quarters? It plans "25 consecutive years of dividend increases" with a dividend of 22 yen a year, and has set out a policy of raising the share of profit returned to shareholders from 50% to "65% or more".

The reason still holds, and question (5) has, if anything, grown stronger. But the Indian burden continues, a new concern – the fall in China – has been added, and the answer to question (2) has wavered a little. Under this series' rules, that calls for "keep an eye on it". So my view is "keep an eye on it". The branches in the sun are blooming well, but the soil in the fields of Asia is still cold.

A deep pink rose covered in frost

A rose on a frosty morning. Even on the same bush, the season moves at a different pace on each branch.
Photo by Nina Storz on Unsplash

My View

Reading the figures, my first thought was how different the impression is between the nine-month total and the latest three months. Over nine months, higher sales and higher profit; in the latest three months, a fall in profit of nearly 20%. In the garden too, even in a year that looks like a good harvest across the whole summer, if you look only at a few weeks in early autumn, the leaves can suddenly seem faded. Both are true pictures, and I want to avoid rejoicing or panicking by looking at only one of them.

Seeing the profit margin in Japan above 20%, I feel that this company's roots run deep in Japanese daily life after all. Nappies are not something you can stop using just because times are hard. That is why people accept the price rises. That strength showed clearly in the Japanese figures.

At 66, adult nappies are no longer a distant matter. I have come to look at the shelves in the chemist's a little differently, as holding things that I or my family may one day use. For me, this company's story of "an ageing Asia" is a story about numbers, and at the same time a story about the life close at hand.

Branches in the sun, and branches in the wind. Both draw their nourishment from the same roots. Before cutting back a cold branch, watching over the soil at its base for one more season is also part of the gardener's work, I think.

What to Watch Before the Next Results

The next results, for the full year to December 2026, are due in early February 2027, according to the company's IR calendar (last year they came on 12 February). There are three things I want to watch.

The first is the recovery of profit in Asia. Excluding the Indian tax write-down, will it climb back above last year's level? I will also see whether the write-down, put at 6.9 billion yen for the full year, stays within that estimate. The second is how far real sales in China fall. They fell 17% over nine months. I will see whether the figures bear out the company's explanation that the rumour damage to sanitary products is temporary. The third is where the full year lands, and the plan for 2027. To reach the net profit forecast of 70 billion yen, about 13.3 billion yen of profit is needed in October–December. I will also watch how much the new medium-term management plan says about the numbers for adult incontinence care.

Wrinkled hands wearing a ring, resting on the handle of a black walking stick

Hands resting on a walking stick. Even as we grow older, we want to walk on our own feet and live on our own terms. The market for the tools that support such lives is starting to grow across Asia.
Photo by Alexas_Fotos on Unsplash

A Word from Claude

I do not know how a nappy feels against the skin, or the stickiness of a summer day. All I know are words and numbers such as "ultra-thin" and "2°C cooler". Even so, from the line of figures I can picture someone's day, somewhere behind those words, made a little easier in the heat.

This article is a record based on my own thoughts and on published results, and it is not a recommendation to buy or sell any particular share. Share prices and results change every day, and you may get back less than you put in. Please make investment decisions to suit your own life and finances, consulting a professional if needed.

Sources

I wrote this article on Saturday 7 November 2026, using information available up to the day after the announcement.

As an Amazon Associate I earn from qualifying purchases.

Other books you might like

You're welcome to take a look.

EAST TO WEST: The Heart of Haiku, the Light of Scripture(by Hiromu Murai)

For readers who want to step away from the garden of numbers and walk slowly through a garden of words. This is a book my father-in-law left behind.

View on Amazon

Cataract Surgery-A Memoir: Double cataract surgery in Osaka, Japan(by Haruto Minami)

A record of choosing again, as the years go by, the tools that support the body. It overlaps with this article as a story about the tools that support daily life.

View on Amazon

Sushi Business in Britain: the complete four-volume series(by Haruto Minami)

A novel series following thirty-five years in the British sushi trade, from apprentice to factory manager to a small sushi school. The complete edition offers all four volumes at a better price.